Israel's Kahr Medical Attracts Investments From Sanofi, Others
This article was originally published in PharmAsia News
Executive Summary
Israel's drug maker Kahr Medical is set to receive $1 million investment from Hadasit Bio Holdings, which in turn is getting $2.1 million from French drug-maker Sanofi-Aventis